Home » Topics » Disease categories and therapies » Endocrine/metabolic

Endocrine/metabolic
RSS

Third approval for Parke-Davis HMG-CoA reductase inhibitor

Dec. 23, 1996

Fujisawa synthesizes novel bone resorption inhibitors

Dec. 20, 1996

Grelan, Fournier collaborate on ACAT inhibitors

Dec. 20, 1996

Shaman and Ono expand diabetes collaboration

Dec. 18, 1996

Pamidronate effective against skeletal complications in breast cancer patients

Dec. 18, 1996

Troglitazone hypotensive, hypoglycemic activities established in preclinical model

Dec. 18, 1996

Licenses offered for the use of IL-7 in increasing hematopoietic stem cells

Dec. 17, 1996

NIH offers glycoprotein hormone superagonists for licensing

Dec. 17, 1996

Oscillin and MAbs against it offered for licensing

Dec. 17, 1996

New bile acid transporter inhibitors in preclinical testing at Searle

Dec. 16, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 10, 2026.
Cas and effect: Merck’s phase III ripples HIF-2α space
BioWorld
Oddsmakers wasted no time figuring the market chances after Merck & Co. Inc. rolled out data from the phase III Litespark-011 study testing its oral...
Brain’s hidden tau-clearing pathway uncovered
BioWorld Science
Researchers at INSERM and collaborators have identified hypothalamic tanycytes as mediators of tau clearance and shown that their structural and genetic...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 10, 2026
MSD synthesizes α-synuclein PET agents
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has prepared and tested new positron emission tomography (PET) agents for binding and imaging α-synuclein (SNCA) for the diagnosis...